Literature DB >> 8797599

The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer.

L H Regimbald1, L M Pilarski, B M Longenecker, M A Reddish, G Zimmermann, J C Hugh.   

Abstract

The MUC 1 mucin is expressed on normal breast epithelium and in 90% of breast cancers. We report here that tumor-associated MUC1 is a ligand for intercellular adhesion molecule 1 (ICAM-1). Antibodies to ICAM-1 and to MUC1 inhibited adhesion of human and transfected mouse MUC1-positive cell lines to human umbilical vein endothelial cell monolayers and immobilized recombinant human ICAM-1-immunoglobulin fusion protein. Purified MUC1 pretreatment of recombinant human ICAM-1 was an equally effective inhibitor of adhesion. The interaction between MUC1 and ICAM-1 may be critical to the process of bloodborne metastases in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797599

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  MUC1 mucin and carbohydrate associated antigens as tumor markers in head and neck squamous cell carcinoma.

Authors:  M V Croce; M E Rabassa; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  Detection and isolation of MUC1 mucin from larynx squamous cell carcinoma.

Authors:  M V Croce; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

Review 3.  Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.

Authors:  Partha Mukhopadhyay; Subhankar Chakraborty; Moorthy P Ponnusamy; Imayavaramban Lakshmanan; Maneesh Jain; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2011-01-26

4.  Influence of sialic acid removal on MUC1 antigenic reactivity in head and neck carcinoma.

Authors:  María V Croce; Martín E Rabassa; Adrián Pereyra; Amada Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

5.  MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1.

Authors:  Jennifer J Rahn; Jeffrey W Chow; Garnet J Horne; Brian K Mah; Joanne T Emerman; Pat Hoffman; Judith C Hugh
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

6.  Raman-Encoded Molecular Imaging with Topically Applied SERS Nanoparticles for Intraoperative Guidance of Lumpectomy.

Authors:  Yu Winston Wang; Nicholas P Reder; Soyoung Kang; Adam K Glaser; Qian Yang; Matthew A Wall; Sara H Javid; Suzanne M Dintzis; Jonathan T C Liu
Journal:  Cancer Res       Date:  2017-06-14       Impact factor: 12.701

7.  Expression of intercellular adhesive molecule-1 in liver cancer tissues andliver cancer metastasis.

Authors:  Jing-Jing Sun; Xin-Da Zhou; Ge Zhou; Yin-Kun Liu
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

8.  MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas.

Authors:  Kepal N Patel; Ellie Maghami; Volkert B Wreesmann; Ashok R Shaha; Jatin P Shah; Ronald Ghossein; Bhuvanesh Singh
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

9.  Expression of B7.1 in a MUC1-expressing mouse mammary epithelial tumour cell line inhibits tumorigenicity but does not induce autoimmunity in MUC1 transgenic mice.

Authors:  M Smith; J M Burchell; R Graham; E P Cohen; J Taylor-Papadimitriou
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

10.  MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.

Authors:  F Guddo; A Giatromanolaki; M I Koukourakis; C Reina; A M Vignola; G Chlouverakis; J Hilkens; K C Gatter; A L Harris; G Bonsignore
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.